Planned CHD interventions | Control group | Intervention group | Adj. absolute difference between control and intervention, post visit(95% CI)* | |||||
---|---|---|---|---|---|---|---|---|
 | Baseline (95% CI) | Post-visit (95% CI) | Baseline (95% CI) | Post-education (95% CI) | Post-values clarification (95% CI) | Post-coaching (95% CI) | Post-visit (95% CI) | |
Any effective CHD risk reducing Strategy†(n = 157) | 25% | 42% | 28% | 62% | 61% | 57% | 63% | 21% |
(15-36%) | (32-52%) | (21-36%) | (50-75%) | (49-73%) | (45-69%) | (49-77%) | (5% to 37%) | |
BP med, if HTN (n = 55 ) | 3% | 29% | 11% | 65% | 65% | 37% | 26% | -3% |
(0-11%) | (5-52%) | (0-24%) | (40-91%) | (45-86%) | (45-81%) | (7-45%) | (-30% to 25%) | |
Cholesterol med, if abnormal chol (n = 69) | 12% | 9% | 5% | 59% | 59% | 47% | 39% | 30% |
(0-26%) | (1-18%) | (0-13%) | (43-75%) | (44%-74%) | (28-67%) | (24-54%) | (14% to 46%) | |
Smoking cessation, if smoking (n = 21) | 60% | 50% | 82% | 70% | 80% | 80% | 80% | 30% |
(25-95%) | (8-92%) | (56-100%) | (35-100%) | (50-100%) | (50-100%) | (51-100%) | (-16% to 76%) | |
Aspirin, if CHD risk >6% and no contra-indication (n = 140) | 12% | 24% | 14% | 40% | 40% | 47% | 43% | 19% |
(8-17%) | (14-33%) | (6-21%) | (27-54%) | (29-52%) | (31-63%) | (24-62%) | (-1% to39%) | |
Diet low in saturated fat, all (n = 157) | 23% | 40% | 20% |  |  | 46% | 29% | -11% |
(12-34%) | (29-51%) | (12-28%) | -- | -- | (44-65%) | (16-42%) | (-27% to 6%) | |
Exercise regularly, all (n = 157) | 35% | 54% | 34% | -- | -- | 56% | 53% | -1 |
(24-47%) | (39-69%) | (23-45Â %) | Â | Â | (42-69%) | (44-62%) | (-17 to 16) |